Cas:17380-78-8 methyl 1-phenylcyclohexane-1-carboxylate manufacturer & supplier

We serve Chemical Name:methyl 1-phenylcyclohexane-1-carboxylate CAS:17380-78-8 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

methyl 1-phenylcyclohexane-1-carboxylate

Chemical Name:methyl 1-phenylcyclohexane-1-carboxylate
CAS.NO:17380-78-8
Synonyms:methyl 1-phenyl-1-cyclohexanecarboxylate;1-Phenylcyclohexane-1-carboxylic acid methyl ester;Cyclohexanecarboxylic acid,1-phenyl-,methyl ester;1-Phenylcyclohexan-1-carbonsaeure-methylester;methyl 1-phenylcyclohexanecarboxylate;methyl 1-phenylcyclohexancarboxylate
Molecular Formula:C14H18O2
Molecular Weight:218.29200
HS Code:2916399090

Physical and Chemical Properties:
Melting point:N/A
Boiling point:N/A
Density:N/A
Index of Refraction:
PSA:26.30000
Exact Mass:218.13100
LogP:3.06150

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:


Contact us for information like methyl 1-phenyl-1-cyclohexanecarboxylate chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,methyl 1-phenylcyclohexancarboxylate physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,methyl 1-phenylcyclohexancarboxylate Use and application,methyl 1-phenylcyclohexanecarboxylate technical grade,usp/ep/jp grade.


Related News: Earlier this year, the company revealed it had broken ground on a 38,000-square-foot commercial cell therapy plant in Lexington, Massachusetts, which is about 10 miles from downtown Boston. Takeda says the new $84 million plant will be used to make cell therapies for cancers and other diseases. N-(m-Tolyl)-1-naphthohydroxamsaeure manufacturers “We welcome a formal review into the interactions between the FDA and Biogen on the path to the approval of aducanumab,” Sandrock said. “A better understanding of the facts is good for everyone involved to assure confidence in both the therapy and the process by which it was approved as we prioritize the issues that affect patients.” 1-morpholino-7-nitro-3-phenyl-1,2,4-benzothiadiazine suppliers Building on this progress, recombinant technologies have been key to optimizing the performance of biocatalytic reagents, for example by facilitating a reduction in the amount of enzyme needed to drive a reaction while at the same time increasing the yield. (Z)-2-(6-fluoro-3,3-dimethyl-3,4-dihydro-(2H)-isoquinolin-1-ylidene)-1-phenylethan-1-one vendor & factory The announcement comes on top of Recipharm’s move into Morocco, which was fueled by local pledges of $500 million. The new facility under construction and due for completion in 2023 will employ 300 and have a capacity of 300 million units annually. ,The announcement comes on top of Recipharm’s move into Morocco, which was fueled by local pledges of $500 million. The new facility under construction and due for completion in 2023 will employ 300 and have a capacity of 300 million units annually.